Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrence Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00873002
What this trial is testing

Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Case Comprehensive Cancer Center 3
Not applicableStudy completedNCT01899261
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver Carcinoma+1 more
Montefiore Medical Center 20
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Not applicableStudy completedNCT06564103
What this trial is testing

Stratification for F-L Therapy After LT

Who this might be right for
Liver TransplantationAdjuvant FOLFOX Plus LenvatinibMachine Learning
Xiao Xu 1
Testing effectiveness (Phase 2)Study completedNCT00257426
What this trial is testing

Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
UNC Lineberger Comprehensive Cancer Center 31
Large-scale testing (Phase 3)Looking for participantsNCT07417397
What this trial is testing

Adjuvant TACE in HCC With High-risk Recurrence Factors

Who this might be right for
Hepatocellular CarcinomaAdjuvantTransarterial Chemoembolization
Guangxi Medical University 442
Testing effectiveness (Phase 2)UnknownNCT05355155
What this trial is testing

Bevacizumab Biosimilar Plus FOLFOX4 in the Treatment of Recurrent HCC After Liver Transplantation

Who this might be right for
Post-orthotopic Liver TransplantationHepatocellular Carcinoma Recurrent
The First Affiliated Hospital with Nanjing Medical University 15
Large-scale testing (Phase 3)Ended earlyNCT01009593
What this trial is testing

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma Non-resectableHepatocellular Carcinoma RecurrentCarcinoma, Hepatocellular+10 more
Abbott 1,035
Not applicableStudy completedNCT05235490
What this trial is testing

Identification of Image Phenotypes to Predict Recurrence After Resection of Hepatocellular Carcinoma

Who this might be right for
CT Scans Prior to Surgery With a Least 2 Years of Follow-up
Assistance Publique - Hôpitaux de Paris 100
Not applicableLooking for participantsNCT05738980
What this trial is testing

Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3

Who this might be right for
Hepatocellular Carcinoma
Beijing Hospital 88
Testing effectiveness (Phase 2)Study completedNCT00365391
What this trial is testing

Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT00410956
What this trial is testing

Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center 22
Not applicableStudy completedNCT02728219
What this trial is testing

Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion

Who this might be right for
Recurrent Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 150
Testing effectiveness (Phase 2)Looking for participantsNCT07014150
What this trial is testing

Neoadjuvant Therapy of Iparomlimab and Tuvonralimab Combined With Lenvatinib for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Resectable
Peking Union Medical College Hospital 33
Not applicableLooking for participantsNCT07064681
What this trial is testing

The Real-world Study of AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)

Who this might be right for
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Sun Yat-sen University 100
Early research (Phase 1)Looking for participantsNCT07594964
What this trial is testing

To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors

Who this might be right for
Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)Pancreatic Ductal Adenocarcinoma (PDAC)Hepatocellular Carcinoma (HCC)+1 more
Shenzhen Xinhe Biomedical 48
Testing effectiveness (Phase 2)UnknownNCT04981665
What this trial is testing

Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

Who this might be right for
Hepatocellular CarcinomaAdjuvant Therapy
Zhejiang University 50
Early research (Phase 1)Study completedNCT02143401
What this trial is testing

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
CirrhosisHepatitis B InfectionHepatitis C Infection+6 more
National Cancer Institute (NCI) 29
Large-scale testing (Phase 3)UnknownNCT00460681
What this trial is testing

Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 220
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06900478
What this trial is testing

Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC

Who this might be right for
Hepatocarcinoma
Hua Li 25
Next Page